ArticleOncotarget2016

Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.

Cheolwon Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.